Citations 1
Post-progression therapy (PPT) effect on survival in AVF2107, a phase III trial of bevacizumab in first-line treatment of metastatic colorectal cancer (mCRC)
Hedrick, Eric, Hurwitz, Herbert I. , Sarkar, Somnath , Griffing, S., Novotny, William , Grothey, Axel
Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 3517-3517
